See latest updates on Pitt's response to the COVID-19 outbreak


Commitment to Research

  • The University is a leading center for academic research
  • The University offers a large and varied biomedical research environment where students have many choices for thesis research.  
  • The University belongs to the American Association of Universities, an organization of 62 leading Public and Private Research Universities in the United States and Canada, founded in 1900
  • The University has ranked among the top 10 recipients of NIH funding, since 1998
  • In FY 2017 according to an analysis of NIH funding, the faculty of the University ranks fifth in dollars awarded, with more than $528 million in total funding and more than 80 percent of this funding going o the School of Health Sciences. The faculty of the medical and public health schools also ranks fifth, with total NIH funding of more than $414 million.
  • In FY 2018, overall, the University  spent approximately $808 million for research of all kinds; approximately 70 percent of this amount was for research in the health sciences. As a result of its success, the School of Medicine has invested significantly in new research infrastructure in disciplines like developmental, cellular, structural, and computational and systems biology and in faculty recruitment.
  • In 2019, US News and World Reports ranks the University of Pittsburgh School of Medicine as number 13 for Research in the United States.

The scope of research within the medical school ranges from fundamental biology to clinical translation.  Areas of research emphasis include

  • drug discovery and design
  • cell signaling
  • transplantation immunology
  • tumor immunology
  • stem cell biology
  • regenerative medicine
  • cancer biology and therapy
  • virology; gene therapy
  • bioinformatics and computational biology
  • basic and clinical neuroscience
  • infectious disease
  • vaccine development
  • hemostasis and vascular biology
  • structural biology
  • developmental biology
  • clinical trials management.